Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 9,795 CDNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | CareDx, Inc. (CDNA) | Grant/Award | 9,795 | n/a |
| Jun 10, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 9,200 | n/a |
| May 29, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 5,093 | n/a |
| Jan 7, 2026 | Intellia Therapeutics, Inc. (NTLA) | Purchase | 150,000 | $1.40M |
| Jun 17, 2025 | CareDx, Inc. (CDNA) | Grant/Award | 12,103 | n/a |
| Jun 13, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 8,000 | n/a |
| Jun 2, 2025 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 16,634 | n/a |
| Aug 8, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jun 18, 2024 | CareDx, Inc. (CDNA) | Grant/Award | 10,570 | n/a |
| Jun 14, 2024 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 7,737 | n/a |